Quadria Capital Acquires Minority Stake in NephroPlus with INR 850 Cr Investment

The transaction supports Hyderabad-based NephroPlus in meeting the increasing demand for dialysis services in India and other Asian markets.

Healthcare-focused private equity (PE) firm Quadria Capital has invested INR 850 Cr in NephroPlus, India's leading dialysis player.

This investment marks Quadria's acquisition of a significant minority stake in NephroPlus through a combination of primary investment and the purchase of shares from existing shareholders, according to the PE firm's official statement.

The transaction is aimed at supporting Hyderabad-based NephroPlus in catering to the growing demand for high-quality and affordable dialysis services across India and other markets in Asia.

According to Vikram Vuppala, founder and CEO of NephroPlus, "Our business has evolved over the past few years, and today we are proud to be one of the fastest growing and most trusted providers of high-quality dialysis to around 30,000 patients."

He stated their commitment to expanding in India, their core market, while also exploring opportunities to extend their expertise and clinical excellence to more patients globally.

According to him, Quadria's healthcare expertise, capital, and focus on operational value creation will further enhance NephroPlus's ability to scale, innovate, and deliver affordable and high-quality care.

Talking about the deal, Sunil Thakur, partner and head of South Asia at Quadria Capital, said, "Quadria's investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations. We look forward to working with their leadership team to continue to expand their footprint, increase access to dialysis services across Asia, and accelerate the next phase of growth for NephroPlus."

NephroPlus’ Future Bet

Established in 2010, Hyderabad-based NephroPlus operates as a dialysis provider in significant and high-growth markets across Asia, including India. The company has been expanding its presence in countries including the Philippines and other Asian nations.

NephroPlus offers dialysis services across various centers in marquee hospitals and standalone clinics, collaborating with leading nephrologists. Additionally, it provides care through public-private partnerships in both urban and rural areas.

With this substantial investment by Quadria Capital, NephroPlus aims to further expand its reach, enhance its service offerings, and deliver affordable and high-quality dialysis care across India and other Asian markets.

Recent Global PE Investments in India

The Indian healthcare industry is witnessing growing interest from global private equity firms driven by factors such as rising demand, favorable demographics, and the potential for consolidation and expansion.

Just days back, Apollo Hospitals Group announced a significant investment deal with private equity firm Advent International. As per the deal, the global PE firm planned to invest INR 2,475 Cr in Apollo HealthCo, a unit of India's leading corporate hospital chain operator, for a 12.1% stake.

Similarly, Temasek, the Singapore sovereign wealth fund, acquired a 41% stake in Bengaluru-based Manipal Hospitals for around $2 billion, making it the majority stakeholder in the hospital chain.